Facial Fracture Risk Up for Older Women With Facial Injury

This article originally appeared here.
Share this content:
Facial Fracture Risk Up for Older Women With Facial Injury
Facial Fracture Risk Up for Older Women With Facial Injury

MONDAY, July 18, 2016 (HealthDay News) -- The risk of facial fracture varies with age, sex, and race, with increased risk among white and Asian older women, according to research published online July 14 in JAMA Facial Plastic Surgery.

Curtis Hanba, from the Wayne State University School of Medicine in Detroit, and colleagues characterized the incidence of facial fractures by patient demographics and injury mechanism in a retrospective analysis of the National Electronic Injury Surveillance System (NEISS). There were 33,825 NEISS entries corresponding to 1,401,196 emergency department visits for adult facial injury; of these, 14.4 percent involved fracture.

The researchers found that among younger individuals (<60 years), a greater proportion of facial injuries were fractures among men than women (15.5 versus 12.5 percent; P < 0.001). In older populations (≥60 years), women had an increased fracture predilection (15.0 versus 14.0 percent; P < 0.001). Older women had a significantly greater fracture risk than younger women, with the comparison significant among whites and Asians; older black women had a significantly decreased fracture risk. Compared with blacks, white and Asian individuals of either sex had significantly greater rates of facial fracture injury on individual comparisons of younger and older cohorts.

"There is an increase in the risk of facial fracture among postmenopausal women sustaining facial injuries, with these results significant among whites and Asians," the authors write. "A decreased risk was noted on comparison of younger and older black women."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »